EADV 2026 HS Capital Markets Call We act with care to create value in the lives of the people we serve
EADV HS Capital Markets Call Bimzelx long term impact on tunnels and potential to prevent disease progression in HSThe briefing has taken place on Thursday October 1st, 2026 on the occasion of the data presentation at EADV The videoconference webcast (including a Q&A session) was hosted by:Emmanuel Caeymaex : Executive Vice President, Head of Patient Evidence (UCB)Professor Amit Garg: Professor & Founding Chair, Department of Dermatology, Zucker School of Medicine at Hofstra/Northwell Professor, Center for Health Innovations & Outcomes Research, Feinstein Institutes for Medical Research Materials Please find the presentation here